Exosomes Derived from Gold Nanorod Engineered Vascular Endothelial Cells Inhibit Tumor Growth via Disrupting the TGFβ Pathway

Exosomes are nanosized extracellular vesicles which are emerging as novel therapeutic nanoparticles. This paper reports a novel concept of engineering exosomes using nanomaterial inside the vascular endothelial cells (ECs). Gold nanorods (GNRs) could inhibit EC division and internalized GNRs located...

Full description

Saved in:
Bibliographic Details
Published inJournal of nanomaterials Vol. 2022; no. 1
Main Authors Zhu, Weiye, Zhang, Rui, Zhao, Zichang, Zhao, Na, Gui, Xiao, Cui, Xiao, Shen, Ni, Zhao, Jiawei, Gao, Guangping, Zhang, Haorui, Huan, Chenyang, Zhou, Yukun, Li, Yanjie, Zhang, Jianhua, Song, Hongyuan, Shen, Wei
Format Journal Article
LanguageEnglish
Published New York Hindawi 2022
Hindawi Limited
Subjects
Biomedical materials
Cancer therapies
Endosomes
Endothelial cells
Engineering
Gold
Ligands
MicroRNAs
Nanomaterials
Nanoparticles
Nanorods
Nanotechnology
Tumors
Online AccessGet full text

Cover

More Information
Summary:Exosomes are nanosized extracellular vesicles which are emerging as novel therapeutic nanoparticles. This paper reports a novel concept of engineering exosomes using nanomaterial inside the vascular endothelial cells (ECs). Gold nanorods (GNRs) could inhibit EC division and internalized GNRs located in endosomes of binucleated ECs. The GNRs could alter the composition of bioactive molecules loaded in exosomes. The engineered EC-derived exosomes could inhibit tumor cell proliferation, migration, and invasion in vitro and suppress tumor growth in vivo. miRNA sequencing showed that the engineered exosomes contained various miRNAs that could disrupt the TGFβ pathway. Further data suggested that the engineered exosomes could suppress the expression of TGFβ1 and TGFβ2, thus inhibiting the activation of SMAD2 and SMAD3. These data highlighted the therapeutic potential of engineering exosomes using nanomaterials.
ISSN:1687-4110
1687-4129
DOI:10.1155/2022/2042754